Liu et al. elucidated the upregulation of GPX3 in MI and delineated its candidacy as a prospective target for heart regeneration therapy through an integrative approach encompassing transcriptomic and proteomic analyses [79]. This evidence concerns the gene GPX3 and myocardial infarction.